“Arbortext has long been a pioneer in XML authoring and publishing software,” said Ron Schmelzer, an analyst at ZapThink LLC, in Cambridge, Mass. “Arbortext has shown that it is able to offer focused software to support every aspect of the drug development lifecycle–from discovery, clinical trials and regulatory approvals to manufacturing, marketing and medical affairs.”
Read more at: eWeek
Jason Bloomberg, President of ZapThink, will be delivering this two-day workshop in London on March 15 & 16, 2012, in partnership with IRM UK.
Click here for more information and to register!
In the News
Arbortext Targeting Life Sciences Industry
FREE POSTERS
ZapThink's Vision for Enterprise IT in 2020
10-pack of prints for just $29.95*
SOA Implementation Roadmap
10-pack of prints for just $29.95*
Copyright © 2012 ZapThink, a Dovèl Technologies Company. 
Discussion
No comments for “Arbortext Targeting Life Sciences Industry”